GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Runben Biotechnology Co Ltd (SHSE:603193) » Definitions » Additional Paid-In Capital

Runben Biotechnology Co (SHSE:603193) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Runben Biotechnology Co Additional Paid-In Capital?


Runben Biotechnology Co's quarterly additional paid-in capital increased from Sep. 2024 (¥0 Mil) to Dec. 2024 (¥1,012 Mil) but then stayed the same from Dec. 2024 (¥1,012 Mil) to Mar. 2025 (¥0 Mil).

Runben Biotechnology Co's annual additional paid-in capital increased from Dec. 2022 (¥99 Mil) to Dec. 2023 (¥1,009 Mil) and increased from Dec. 2023 (¥1,009 Mil) to Dec. 2024 (¥1,012 Mil).


Runben Biotechnology Co Additional Paid-In Capital Historical Data

The historical data trend for Runben Biotechnology Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Runben Biotechnology Co Additional Paid-In Capital Chart

Runben Biotechnology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial 117.20 98.94 98.94 1,009.48 1,012.19

Runben Biotechnology Co Quarterly Data
Dec19 Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1,009.48 - 1,012.19 -

Runben Biotechnology Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Runben Biotechnology Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Runben Biotechnology Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Runben Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Xinzhuang 5th Road, Guangzhou Economic and Technological Development Zone, Guangdong, Guangzhou, CHN, 510627
Runben Biotechnology Co Ltd is engaged in research & development, production and sales of mosquito repellent and personal care products.

Runben Biotechnology Co Headlines

No Headlines